According to a website based prediction tool, Targetscan, Fpn is a potential target for miR-124, which is a brain-enriched miRNA [51] that is specifically upregulated in the hippocampus and temporal cortex of AD patients [35]. The gene discussed is SLC40A1; the disease is Alzheimer disease.